PHAR
Setback for Novo Nordisk: Alzheimer’s Drug Trials Fall Short, Impacting Weight Loss Innovation
Novo Nordisk recently faced a significant blow when its trials for an older version of its semaglutide drug failed to ... Read more
Dow Hits Record High as Traders Anticipate End of Government Shutdown: What It Means for Your Investments
The Dow Jones Industrial Average recently hit a record high, boosted by hopes of an end to the lengthy U.S. ... Read more
Metsera Embraces Pfizer’s $10 Billion Offer: An Inside Look at the Latest M&A Showdown
On November 7, 2023, Metsera, a company developing obesity drugs, accepted a $10 billion offer from Pfizer. This move seems ... Read more
Kimberly-Clark’s Bold Move: Acquiring Tylenol Maker Kenvue for Over $40 Billion – What It Means for You
Kimberly-Clark, known for products like Kleenex, is making waves with its announcement to acquire Kenvue, the parent company of Tylenol, ... Read more
US Health Chief: Insufficient Data Connecting Tylenol to Autism Risks
U.S. Health Secretary Robert F. Kennedy Jr. recently spoke about the use of Tylenol (acetaminophen) during pregnancy. He emphasized that ... Read more
